Related Experiment Video
Updated: Nov 28, 2025

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
Published on: July 22, 2021
Something Old, Something New: the ACR Gout Treatment Guideline and Its Evolution from 2012 to 2020
Rebecca E Cohen1, Michael H Pillinger1,2, Michael Toprover3,4,5
1Division of Rheumatology, NYU Grossman School of Medicine, New York, NY, USA.
Insights
The 2020 American College of Rheumatology (ACR) gout guidelines update the 2012 recommendations, offering evidence-based strategies for managing gout flares, urate-lowering therapy, and lifestyle changes.
Area of Science:
- Rheumatology
- Internal Medicine
Background:
- Gout is a prevalent inflammatory arthritis affecting 4% of US adults.
- The American College of Rheumatology (ACR) published gout management guidelines in 2012 and updated them in 2020.
Purpose of the Study:
- To compare the 2012 ACR gout guidelines with the 2020 ACR gout guidelines.
- To summarize key similarities and differences between the two guideline sets.
Main Methods:
- Review and analysis of the 2012 and 2020 ACR gout guidelines.
- Comparison of methodological approaches (RAND vs. GRADE) and specific recommendations.
Main Results:
- Identified similarities and key differences in recommendations for gout flare treatment, imaging, urate-lowering therapy, lifestyle, and genetic testing.
- Discussed the evidence-based approach and rationale behind the recommendations in both guidelines.
Conclusions:
- The 2020 ACR guidelines provide an updated, evidence-based approach to gout management.
- Key differences exist in treatment strategies, reflecting advancements in the understanding and management of gout.
Purpose Of Review:
Gout is the most common inflammatory arthritis in the USA, affecting about 4% of all adults. The American College of Rheumatology (ACR) released a new guideline in 2020 to help with the management of gout. This guideline serves as an update to the previous set of guidelines which the ACR published in 2012. The purpose of this review is to compare the 2012 ACR gout guidelines to the newly released 2020 ACR gout guidelines.
Recent Findings:
There are many similarities between the two guidelines, and also several key differences. The 2020 guidelines assist in the clinical management of gout by healthcare providers. Additionally, the new guidelines utilize newer literature to help create an evidence-based approach to the treatment for gout. We discuss the methodological approach to each guideline (RAND versus GRADE), as well as the final recommendations for gout flare treatment, use of imaging, urate-lowering therapy, lifestyle changes, and genetic testing prior to initiation of allopurinol in each guideline, as well as lingering issues that the 2020 guidelines have not addressed. We dissect both the 2012 and 2020 ACR gout guidelines to summarize the key similarities and differences between the two as well as discuss how the authors came to the recommendations that they did for each set of guidelines.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Urinary Tract Calculi III: Medical Management
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

